BNP Paribas Financial Markets’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,962
| Closed | -$4K | – | 3627 |
|
2021
Q3 | $4K | Sell |
1,962
-549
| -22% | -$1.12K | ﹤0.01% | 3123 |
|
2021
Q2 | $7.46K | Sell |
2,511
-3,932
| -61% | -$11.7K | ﹤0.01% | 3174 |
|
2021
Q1 | $17.8K | Sell |
6,443
-3,240
| -33% | -$8.94K | ﹤0.01% | 3207 |
|
2020
Q4 | $23.5K | Buy |
9,683
+531
| +6% | +$1.29K | ﹤0.01% | 3155 |
|
2020
Q3 | $19.2K | Buy |
9,152
+7,335
| +404% | +$15.4K | ﹤0.01% | 3218 |
|
2020
Q2 | $6.87K | Sell |
1,817
-9,321
| -84% | -$35.2K | ﹤0.01% | 3246 |
|
2020
Q1 | $21.1K | Buy |
11,138
+2,500
| +29% | +$4.73K | ﹤0.01% | 3283 |
|
2019
Q4 | $18.1K | Buy |
8,638
+6,978
| +420% | +$14.6K | ﹤0.01% | 3359 |
|
2019
Q3 | $3.97K | Buy |
+1,660
| New | +$3.97K | ﹤0.01% | 3654 |
|
2019
Q2 | – | Sell |
-31
| Closed | -$154 | – | 3939 |
|
2019
Q1 | $154 | Hold |
31
| – | – | ﹤0.01% | 3617 |
|
2018
Q4 | $139 | Buy |
+31
| New | +$139 | ﹤0.01% | 3467 |
|
2018
Q2 | – | Sell |
-5,472
| Closed | -$48.4K | – | 3796 |
|
2018
Q1 | $48.4K | Sell |
5,472
-446
| -8% | -$3.95K | ﹤0.01% | 3001 |
|
2017
Q4 | $42.9K | Buy |
5,918
+3,779
| +177% | +$27.4K | ﹤0.01% | 3081 |
|
2017
Q3 | $14.8K | Sell |
2,139
-158
| -7% | -$1.09K | ﹤0.01% | 3215 |
|
2017
Q2 | $16.4K | Buy |
+2,297
| New | +$16.4K | ﹤0.01% | 3215 |
|